The forecast for Germany's tuberculosis treatment success rate for newly treated cases from 2024 to 2028 remains consistently at 70%. This stability suggests no expected improvement compared to the actual 2023 figure. Given the unchanged value over the forecast period, the year-on-year variation is zero, indicating a static trend with no growth or decline. The compound annual growth rate (CAGR) for 2024-2028 is also zero, reflecting no anticipated advancement in treatment success rates.

Future trends to monitor include:

Innovations in tuberculosis treatment methods and medications.
Policy changes or health initiatives aimed at enhancing treatment outcomes.
Emerging resistance patterns to current TB treatments.
Impact of societal and demographic changes on TB incidence and treatment success.